Prevalence of Helicobacter pylori infection in coronary artery disease and effect of its eradication on coronary lumen reduction after percutaneous coronary angioplasty

Digestive and Liver Disease

Volumn 33, Issue 3, 2001, Pages 222-229

  Kowalski, M ^c   Konturek, P C ^a   Pieniazek, P ^b   Karczewska, E ^b   Kluczka, A ^c   Grove, R ^c   Kranig, W ^c   Nasseri, R ^c   Thale, J ^c   Hahn, E G ^a   Konturek, S J ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^c Hertzcentrum Osnabruck Bad R ^*  (Germany)

Author keywords

CagA; Chlamydia pneumoniae; Coronary artery disease; Helicobacter pylori; IgG; Immune response; Inflammation; Interleukins

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN; BACTERIAL PROTEIN; BACTERIUM ANTIBODY; BLOOD CLOTTING FACTOR; CAGA PROTEIN; CARBON 13; CLARITHROMYCIN; CYTOKINE; CYTOTOXIN; IMMUNOGLOBULIN G; INTERLEUKIN 1BETA; INTERLEUKIN 8; LIPID; OMEPRAZOLE; PLACEBO; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UREA;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD LEVEL; BREATH ANALYSIS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC INFLAMMATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; CYTOKINE RELEASE; DISEASE ASSOCIATION; ERADICATION THERAPY; FEMALE; GASTROINTESTINAL INFECTION; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; SEROPREVALENCE; STATISTICAL ANALYSIS; STOMACH; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADULT; AGE DISTRIBUTION; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CASE-CONTROL STUDIES; COMORBIDITY; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; POLAND; PREVALENCE; RECURRENCE; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; TREATMENT OUTCOME;

EID: 14344276539     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan DP, et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 1994;71:437-9.
2. Patel P, Mendall MA, Carrington D, Strachan DP, Leatham E, Molineaux N, et al. Associations of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. Br Med J 1995;311:711-4.
3. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997:350:430-6.
4. Ossewaarde JM, Feskens EJ, De Vries A, Vallinga CE, Kromhout D. Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not. Epidemiol Infect 1998;120:93-9.
5. Lorber B. Are all diseases infections? Ann Intern Med 1996;125:844-51.
6. Ellis RW. Infection and coronary heart disease. J Med Microbiol 1997;46:535-9.
7. Niemela S, Karttunen T, Korhonen T, Laara E, Karttunen R, Ikaheimo M, et al. Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations? Heart 1996;75:373-5.
8. de Luis DA, Garcia-Avello A, Lasuncion MA, Aller R, Martin de Argua C, Boixeda de Miquel D, et al. Improvement in lipid and haemostasis patterns after Helicobacter pylori infection eradication in type 1 diabetic patients. Clin Nutr 1999;18:227-31.
9. Pasceri V, Cammarota G, Patti G, Couco L, Gasbarrini A, Grillo RL, et al. Association of virulent Helicobacter pylori strains with ischemic heart disease. Circulation 1998;97:1675-9.
10. Pellicano R, Parravicini PP, Bigi R, La Rovere MT, Baduini G, Gandolfo N, et al. Patients with acute myocardial infarction in northern Italy are often infected with H. pylori. Panminerva Med 1999;41:279-80.
11. Abdelmouttaleb I, Danchin N, Ilardo C, Aimone-Gastin I, Angioi M, Lozniewski A, et al. C-reactive protein and coronary artery disease: additional evidence of the implication of an inflammatory process in acute coronary syndromes. Am Heart J 1999;137:346-51.
12. Gasbarrini A, Franceschi F, Cammarota G, Pola P, Gasbarrini G. Vascular and immunological disorders associated with Helicobacter pylori infection. Ital J Gastroenterol Hepatol 1998;30:115-8.
13. Stone AF, Mendall MA. Helicobacter pylori is an aetiological factor for ischaemic heart disease: the case in favour. Digest Liver Dis 2000;32:62-4.
14. Gasbarrini A, Cremonini A, Armuzzi V, Ojetti M, Candelli C, Di Campli C, et al. Helicobacter pylori in cardiovascular and cerebrovascular diseases. J Physiol Pharmacol 1999;50:735-42.
15. Pieniazek P, Karczewska E, Duda A, Tracz W, Konturek SJ. Association of Helicobacter pylori infection with coronary heart diseasae. J Physiol Pharmacol 1999;50:743-52.
16. Mendall MA, Patel P, Asante M, Ballam L, Morris J, Strachan DP, et al. Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart 1997;78:273-7.
17. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C-reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. Br Med J 1996;312:1061-5.
18. Murray LJ, Bamford KB, O'Reilly DP, McCrum EE, Evans AE. Helicobacter pylori infection: relation with cardiovascular risk factors, ischaemic heart disease, and social class. Br Heart J 1995;74:497-501.
19. Menge H, Lang A, Brosius B, Hopert R, Lollgen H. Helicobacter pylori and coronary heart diseases - hypotheses and facts. Z Gastroenterol 2000;38:315-23.
20. Birnie DH, Holme ER, McKay IC, Hood S, McColl KE, Hillis WS. Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Possible mechanism of action of Helicobacter pylori and other bacterial infections in increasing cardiovascular risk. Eur Heart J 1998;19:387-94.
21. Odenbreit S, Puls J, Sendlmaier B, Gerland E, Fischer W, Haas R. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 2000;287:1497-500.
22. Asahi M, Azuma T, Ito S, Ito Y, Suto H, Nagai Y, et al. Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells. J Exp Med 2000;191:593-602.
23. Stein M, Rappuoli R, Corvacci A. Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation. Proc Natl Acad Sci 2000;97:1263-8.
24. Corvacci A, Rappuoli R. Tyrosine-phosphorylated bacterial proteins: Trojan horses for the host cell. J Exp Med 2000;191:587-92.
25. Walsh JH. CagA protein from Helicobacter pylori is a Trojan horse to epithelial cells. Gastroenterology 2000;118:817-8.
26. Pellicano R, Broutet N, Ponzetto A, Megraud F. Helicobacter pylori: from the stomach to the heart. Eur J Gastroenterol Hepatol 1999;11:1335-7.
27. Farsak B, Yildirir A, Akyon Y, Pinar A, Oc M, Boke E, et al. Detection of Chlamydia pneumoniae and Helicobacter pylori in human DNA atherosclerotic plaques by PCR. J Clin Microbiol 2000;38:4408-11.
28. Ameriso SF, Fridman EA, Leiguarda RC, Sevlever GE. Detection of Helicobacter pylori in human carotic arterosclerotic plaques. Stroke 2001;32:385-91.
29. 13C urea breath test in diagnosis of Helicobacter pylori infection. J Physiol Pharmacol 1996;47:545-53.
30. Kaykov E, Abbou B, Friedstrom S, Hermoni D, Roquin N. Chlamydia pneumoniae in ischaemic heart disease. Isr Med Assoc J 1999;1:225-7.
31. Kowalski M, Konturek JW, Kluczka A, Nasseri R. Incidence of infection with Helicobacter pylori in patients with coronary artery disease. J Physiol Pharm 1999;50(Suppl 2):A28.
32. Kowalski M, Konturek JW, Konturek SJ, Kluczka A, Grove R, Krani W, et al. Helicobacter pylori infection - a new cardiovascular risk factor? Book of Abstracts: 7th World Congress of Cardiac Rehabilitation and secondary Prevention. Manilla 2000:AOP03.
33. Wald NJ, Law MR, Morris JK, Bagnall AM. Helicobacter pylori infection and mortality from ischaemic heart disease: negative result from a large, prospective study. Br Med J 1997;315:1199-201.
34. Strachan DP, Mendall MA, Carrington D, Butland BR, Yarnell JW, Sweetnam PM, et al. Relation of Helicobacter pylori infection to 13-year mortality and incident ischaemic heart disease in the caerphilly prospective heart disease study. Circulation 1998;98:1286-90.
35. Tsai C-J, Huang T-Y. Relation of Helicobacter pylori infection and angiographically demonstrated coronary artery disease. Dig Dis Sci 2000;45:1227-32.
36. Bielanski W. Epidemiological study on Helicobacter pylori infection and extragastroduodenal disorders in Polish population. J Physiol Pharmacol 1999:50:723-34.
37. Parente F, Bianchi Porro G. The association between Helicobacter pylori infection and ischemic heart disease: facts or fancy? Helicobacter 1997;2(Suppl.1):67-72.
38. Masotti M, Serra A, Betriu A. Stents and de nova coronary lesions. Meta-analysis. Rev Esp Cardiol 1997;50(Suppl 2):3-9.
39. Ericson K, Saldeen TG, Linquist O, Pahlson C, Mehta JL. Relationship of Chlamydia pneumoniae infection to severity of human coronary atherosclerosis. Circulation 2000;101:2568-71.
40. Romeo F, Martuscelli E, Chirieolo G, Cerabino LM, Ericson K, Saldeen TG, et al. Seropositivity against Chlamydia pneumonia in patients with coronary atherosclerosis. Clin Cardial 2000;23:327-30.